In the realm of Clinical Trial Management Solutions (CTMS), nuvoteQ has emerged as a trailblazing force, offering innovative and cost-effective solutions that transcend geographical boundaries. As nuvoteQ gears up to feature in the upcoming edition of Medhealth Review magazine, dedicated to Clinical Trial Management Solution Providers in 2023, this profile unveils the distinctive facets of a company that is revolutionizing the CTMS landscape.
Headquartered in Pretoria, South Africa, nuvoteQ commenced its journey in 2014 with a vision that transcends borders. Unlike many CTMS providers, nuvoteQ has not only focused on delivering cutting-edge solutions but has also maintained a steadfast commitment to serving countries with limited resources. Their mantra, “Our technology solutions are built locally, but trusted globally,” encapsulates their unique approach. As a testament to their quality, all their platforms adhere rigorously to the FDA CFR-11 and Annexure 11 regulatory guidelines.
nuvoteQ have introduced some modules into their CTMS (called “Kronus”) which are very unique, on a global scale, where they assist QA and HR teams manage all staff training records (using their robust eLearning module) as well as their individual performance, harnessing the power and configurability of their Employee Performance Management (EPM) module within their CTMS solution.
A common challenge faced by clients in the CTMS space is the prohibitive cost of adopting modern solutions. Most providers operate from Europe or the US, making it challenging for organizations in resource-constrained settings to embrace these solutions. nuvoteQ stands out by offering a robust solution stack that not only maintains high quality but also fits within the budgetary constraints of such organizations. This affordability is a pivotal differentiator and a testament to their commitment to providing accessible solutions.
“We entered the market with the goal of not charging startup consulting fees when we onboard a new customer. We have many customers who can attest to this, and we believe that this shows commitment from our side to help build a long-lasting relationship with our customers,” says Adriaan Kruger, Co-Founder & CEO of nuvoteQ.
nuvoteQ’s engagement extends far beyond merely delivering solutions. They have a strong belief in building long-lasting relationships with their clients, evident from their decision to make their solution(s) available at no cost for small research clinics and members within the academic community. Moreover, nuvoteQ actively participates in the wider public health landscape in Africa, offering strategic consulting to align its clients with broader digitization strategies of organizations like the Africa CDC, local Research Ethics Committees (RECs) and National Regulatory Agencies (NRAs). Their involvement reflects their dedication to the larger mission of healthcare advancement.
nuvoteQ’s innovative solutions are driving them ahead in a competitive market. Their solutions are constructed locally but offer globally recognized quality, and their pricing structure is tailored to meet the needs of organizations in LMIC settings.
One compelling case study highlights their transformative impact. Many clients who couldn’t afford cloud-based CTMS solutions were forced to rely on outdated methods like Excel and paper for managing clinical trial data. nuvoteQ partnered closely with these clients to design and build a modern, modular, and secure cloud-based CTMS platform that complies with FDA CFR Part 11 and EMA Annexure 11. Importantly, they offered this solution at an affordable price, bridging the gap for organizations in LMIC settings.
“We have been approached by many customers who can’t afford cloud-based CTMS solutions who are forced to make use of Excel and paper to manage and track progress of the respective elements within their studies. We worked closely with them to design and build a modern, modular, and secure cloud-based CTMS platform, fully compliant with FDA CFR Part 11 and EMA Annexure 11, but offered to customers in LMIC settings at an affordable price,” continues Adriaan.
As for the future, nuvoteQ has its sights set on expansion. With headquarters in South Africa and offices in Cape Town (South Africa), Bangalore (India), and Belo Horizonte (Brazil), they are primed for growth. Their goal is to open an office in Eastern Europe within the next two years, further expanding their footprint in LMIC settings. As they grow, they aim to explore opportunities in the developed world, leveraging their unique combination of cost-effectiveness and quality.
nuvoteQ’s journey in the CTMS landscape is a testament to its commitment to quality, affordability, and a global vision rooted in local expertise. As they continue to pioneer innovative solutions and expand their global footprint, nuvoteQ is poised to make a lasting impact on clinical trials, transcending geographical boundaries and ensuring accessible healthcare solutions for all.